Suicidality in children and adolescents being treated with antidepressant medications
2004
(For resources, this is the publication date. For programs, this is the date posted.)
Information
Guidelines/Recommendations
U.S. Food and Drug Administration (FDA)
See This Resource
FDA Public Health Advisory announcing a multi-pronged strategy to warn the public about the increased risk of suicidal thoughts and behavior (“suicidality”) in children and adolescents being treated with antidepressant medications.